Long-Term Outcome after Bone Marrow Transplantation for Aplastic Anemia Using Cyclophosphamide and Total Lymphoid Irradiation as Conditioning Regimen
Open Access
- 1 January 2008
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 14 (1) , 43-49
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Bone marrow transplantation for patients with acquired severe aplastic anemia using cyclophosphamide and antithymocyte globulin: the experience from a single centerThe Hematology Journal, 2003
- Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patientsBlood, 2000
- Long-Term Survival and Late Deaths after Allogeneic Bone Marrow TransplantationNew England Journal of Medicine, 1999
- Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemiaBlood, 1994
- Malignant Tumors Occurring after Treatment of Aplastic AnemiaNew England Journal of Medicine, 1993
- Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcomeBlood, 1992
- Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment resultsBlood, 1989
- Total lymphoid irradiation and cyclophosphamide as preparation for bone marrow transplantation in severe aplastic anemiaBlood, 1980
- A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemiaBlood, 1979
- APLASTIC ANAEMIA TREATED BY MARROW TRANSPLANTATIONThe Lancet, 1972